ACUTAAS3,458.40

Acutaas Chemicals Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersANURASAETHERBLUEJETCAPLIPOINTCONCORDBIOEMCUREJBCHEPHARMERISMcap ₹28,314 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations717.51,006.91,339.41,461.8
Other Income7.516.941.627.4
Total Income725.01,023.81,381.01,489.3
Expenses
+ Cost of Materials Consumed440.2569.8595.0656.7
+ Changes in Inventories-28.5-17.6-29.0-48.8
+ Employee Benefit Expense63.183.7117.6132.1
+ Finance Costs5.96.23.33.8
+ Depreciation & Amortisation16.126.636.037.7
+ Other Expenses114.2139.0175.4179.4
Total Expenses611.0807.6898.2960.7
EBITDA128.5232.1480.4542.6
EBIT112.4205.5444.4504.9
Profit
PBT before Exceptional Items114.0216.2482.7528.6
+ Exceptional Items-32.10.00.00.0
Pretax Income81.9216.2482.7528.6
+ Current Tax29.049.2117.2131.7
+ Deferred Tax4.26.69.29.5
Tax Expense33.255.7126.4141.2
Net Income48.7160.4356.4387.4
+ Net Income — Continuing Ops48.7160.4356.4387.4
+ Other Comprehensive Income-7.2-0.1-3.2-5.3
Total Comprehensive Income41.5160.3353.1382.0
Net Income to Common42.8158.7356.3386.2
Minority Interest5.91.70.11.1
Per Share
Basic EPS11.6719.8143.5147.17
Diluted EPS11.6619.8143.3747.00
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.1-3.2-5.3
+ Items NOT to be Reclassified to P&L-0.0-0.2-0.40.0
+ Tax on Items NOT to be Reclassified-0.0-0.1-0.1
+ Items to be Reclassified to P&L-7.2-3.0
Comprehensive Income — Owners of Parent35.5158.6353.0306.6
Comprehensive Income — Non-controlling Interests6.01.70.10.4
Per Share — as-filed variants
Basic EPS — Continuing Operations11.6719.8143.5147.17
Diluted EPS — Continuing Operations11.6619.8143.3747.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit305.8454.7773.4854.0
Gross Margin %42.6245.1657.7458.42
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)114.0216.2482.7528.6
− Exceptional Items (reconciliation)-32.10.00.00.0
Net Income Adj (tax-effected)67.8160.4356.4387.4
EPS Adj16.2419.8143.5147.17
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.005.005.005.00
Paid Up Equity Capital36.940.940.940.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.